Compare NWBI & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NWBI | PLSE |
|---|---|---|
| Founded | 1896 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.5B |
| IPO Year | 2009 | 2015 |
| Metric | NWBI | PLSE |
|---|---|---|
| Price | $12.42 | $20.64 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 1 |
| Target Price | $13.67 | ★ $22.00 |
| AVG Volume (30 Days) | ★ 1.3M | 224.5K |
| Earning Date | 04-27-2026 | 05-07-2026 |
| Dividend Yield | ★ 6.44% | N/A |
| EPS Growth | ★ 16.46 | N/A |
| EPS | ★ 0.92 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $6.29 | $840.00 |
| Revenue Next Year | $5.06 | $287.54 |
| P/E Ratio | $13.51 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.75 | $12.56 |
| 52 Week High | $13.62 | $26.30 |
| Indicator | NWBI | PLSE |
|---|---|---|
| Relative Strength Index (RSI) | 48.06 | 50.37 |
| Support Level | $11.93 | $13.75 |
| Resistance Level | $12.91 | $23.18 |
| Average True Range (ATR) | 0.29 | 1.45 |
| MACD | 0.05 | -0.10 |
| Stochastic Oscillator | 44.67 | 44.13 |
Northwest Bancshares Inc is a stockholding company for Northwest Bank. Northwest Bank is a stock savings bank and a community-oriented financial institution offering personal and commercial banking business solutions, investment management, trust services, and insurance products. It also offers consumer finance loans through a wholly-owned subsidiary. The bank's loan portfolio segment consists of personal banking and business banking loans. Personal banking includes residential mortgages, home equity loans, and other consumer loans. Business banking loans consist of commercial real estate loans and commercial loans. Net interest income is the company's primary contributor to revenue.
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.